Fortress Biotech, Inc. (FBIOP:NASDAQ) closed at $13.60 on November 20, 2026, down 1.09% on the day. The stock trades 36.5% below its 52-week high of $21.43 and 109.2% above its 52-week low of $6.50. Fortress Biotech, Inc. is part of the Health Care sector (Major Pharmaceuticals).
In 252 trading sessions since November 20, 2025, FBIOP closed higher on 121 days (48%). Its best day was January 13, 2026 (+23.51%) and its worst was January 7, 2026 (-6.30%). The stock moved 10% or more in a single session 3 times. It opened at least 5% above the previous day's high 2 times.
Fortress Biotech Inc is a biopharmaceutical company. The Company is engaged in the development of novel immunotherapy agents for the treatment of autoimmune diseases and cancer.
Find more stocks like FBIOP with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.